Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-16 9:18 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | PERCEPTIVE ADVISORS LLC | 12,594,211 10.1% | 3,683,060 (+41.33%) | View |
| 2023-03-01 3:30 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Nautilus Biotechnology Inc. NAUT | 18,947,732 15% | 18,947,732 (New Position) | View |
| 2023-02-13 4:15 pm Purchase | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | Cercano Management LLC | 7,172,985 5.8% | 7,172,985 (New Position) | View |
| 2022-02-14 4:11 pm Purchase | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | RA CAPITAL MANAGEMENT L.P. | 2,436,430 2% | 2,436,430 (New Position) | View |
| 2022-02-10 4:19 pm Purchase | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | VCVC V LLC | 7,172,985 5.8% | 7,172,985 (New Position) | View |
| 2021-08-25 8:58 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | McIlwain Matthew S | 6,368,136 5.13% | 6,368,136 (New Position) | View |
| 2021-06-30 2:26 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | AH Bio Fund II L.P. | 17,653,917 14.2% | 17,653,917 (New Position) | View |
| 2021-06-21 5:00 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | PERCEPTIVE ADVISORS LLC | 8,911,151 7.2% | 8,911,151 (New Position) | View |
| 2021-06-16 5:10 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Mallick Parag | 21,153,911 17% | 21,153,911 (New Position) | View |
| 2021-06-16 5:07 pm Purchase | 13D | NAUTILUS BIOTECHNOLOGY INC NAUT | Patel Sujal M | 17,497,732 14% | 17,497,732 (New Position) | View |
| 2021-06-11 5:35 pm Purchase | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | ARYA Sciences Holdings III | 4,146,500 3.3% | 4,146,500 (New Position) | View |
| 2021-02-16 4:46 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | ARYA Sciences Holdings III | 4,146,500 21.6% | 4,146,500 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.7% | 1,000,000 (New Position) | View |
| 2021-02-05 5:51 pm Purchase | 13G | NAUTILUS BIOTECHNOLOGY INC NAUT | BlackRock Inc. BLK | 1,000,000 6.5% | 1,000,000 (New Position) | View |
| 2020-08-13 4:16 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | Bain Capital Life Sciences Fund II L.P. | 891,429 5.8% | 891,429 (New Position) | View |